Verastem Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.34

+0.13 (+3.09%)

As of Jun 24, 2:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +223.7% upside

Low Target $11.84

Average Target $14.05

High Target $17.49

Current Price $4.34

Current
$4.34

Target
$14.05

$11.84 $14.05 avg $17.49

Scenario Analysis

Bear Case

$11.84

172.8%

Low target

Base Case

$14.05

+223.7%

Avg target

Bull Case

$17.49

+303.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$11.25

-61.4% from high

52-Week Low

$3.55

+22.3% from low

Target vs 52W High

$14.05

+24.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.9%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.4%